Stay updated on IMM60 and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.

Latest updates to the IMM60 and Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision tag 'Revision: v3.4.2' is added to the history, and the page removes a funding-notice about government operations as well as the earlier 'Revision: v3.4.1' entry. These are minor version-tracking updates and do not alter study data or core page content.SummaryDifference0.8%

- Check21 days agoChange DetectedNotice about government funding and operating status added; revision history updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedUI changes to the study record history include a Show glossary option, visual color coding for changes, and new revision labeling (Revision: v3.4.0) replacing prior labeling. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedRevision: v3.3.4 is added and v3.3.3 removed on the page, a minor site version update that does not affect trial data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 to the Record History and removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Record History adds revision v3.3.2 and removes v3.2.0 in the version list.SummaryDifference0.1%

Stay in the know with updates to IMM60 and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.